Yuki Homma

1.1k total citations
49 papers, 684 citations indexed

About

Yuki Homma is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuki Homma has authored 49 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 25 papers in Surgery and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuki Homma's work include Pancreatic and Hepatic Oncology Research (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Gallbladder and Bile Duct Disorders (13 papers). Yuki Homma is often cited by papers focused on Pancreatic and Hepatic Oncology Research (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Gallbladder and Bile Duct Disorders (13 papers). Yuki Homma collaborates with scholars based in Japan and United States. Yuki Homma's co-authors include Itaru Endo, Ryusei Matsuyama, Takashi Murakami, Rintaro Mori, Robert M. Hoffman, Yukihiko Hiroshima, Kuniya Tanaka, Takafumi Kumamoto, Yasushi Ichikawa and Kentaro Miyake and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Letters and Medicine.

In The Last Decade

Yuki Homma

46 papers receiving 679 citations

Peers

Countries citing papers authored by Yuki Homma

Since Specialization

Citations

This map shows the geographic impact of Yuki Homma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Homma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Homma more than expected).

Fields of papers citing papers by Yuki Homma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Homma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Homma. The network helps show where Yuki Homma may publish in the future.

Co-authorship network of co-authors of Yuki Homma

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Homma. A scholar is included among the top collaborators of Yuki Homma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Homma. Yuki Homma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of Conversion Surgery for Initially Unresectable Biliary Tract Cancer That Has Responded to Down-Staging Chemotherapy 2025 ·Cancers ·Takashi Murakami, (unknown), Yasuhiro Yabushita, Yuki Homma, Yu Sawada, Kentaro Miyake, (unknown), Kazuhisa Takeda, Shin Maeda, Shoji Yamanaka, (unknown)	1
2	Clinical Relevance of High-Grade Pancreatic Intraepithelial Neoplasia at the Pancreatic Transection Margin in Patients with Pancreatic Ductal Adenocarcinoma 2025 ·Annals of Surgical Oncology ·Kei Kobayashi, Yu Sawada, Kota Sahara, (unknown), Kentaro Miyake, Yasuhiro Yabushita, Yuki Homma, (unknown), Ryusei Matsuyama, Itaru Endo	0
3	Incidence and Prognostic Implications of Lymphovascular Invasion in Node‐Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group 2024 ·Journal of Surgical Oncology ·Kota Sahara, Diamantis I. Tsilimigras, Yuki Homma, Jun Kawashima, Shishir K. Maithel, Flavio G. Rocha, Sharon M. Weber, Ryan C. Fields, Kamran Idrees, George A. Poultsides, Cliff Cho, Itaru Endo, Timothy M. Pawlik	2
4	Neoadjuvant Therapy for Extrahepatic Biliary Tract Cancer: A Propensity Score-Matched Survival Analysis 2023 ·Journal of Clinical Medicine ·(unknown), Kota Sahara, T Takahashi, Kentaro Miyake, Yasuhiro Yabushita, Yu Sawada, Yuki Homma, Ryusei Matsuyama, Itaru Endo, Timothy M. Pawlik	9
5	Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma 2022 ·Annals of Surgical Oncology ·Ryusei Matsuyama, Rintaro Mori, (unknown), Yuki Homma, (unknown), (unknown), Takashi Murakami, Yu Sawada, Kentaro Miyake, Yasuhiro Shimizu, Takafumi Kumamoto, Itaru Endo	13
6	Real-time mortality risk calculator following pancreatoduodenectomy: quantifying the impact of perioperative events 2022 ·HPB ·Kota Sahara, Kentaro Miyake, Diamantis I. Tsilimigras, Yuki Homma, Takafumi Kumamoto, Ryusei Matsuyama, Joal D. Beane, Itaru Endo, Timothy M. Pawlik	1
7	Survival Benefit of Primary Tumor Resection Among Elderly Patients with Pancreatic Neuroendocrine Tumors 2021 ·World Journal of Surgery ·(unknown), Kota Sahara, Diamantis I. Tsilimigras, Kentaro Miyake, Yasuhiro Yabushita, Yuki Homma, Takafumi Kumamoto, Ryusei Matsuyama, Timothy M. Pawlik	6
8	Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model 2020 ·Cancer Letters ·Jun Yamamoto, Kentaro Miyake, Qinghong Han, Yuying Tan, Sachiko Inubushi, Norihiko Sugisawa, Takashi Higuchi, Yoshihiko Tashiro, Hiroto Nishino, Yuki Homma, Ryusei Matsuyama, Sant P. Chawla, Michael Bouvet, Shree Ram Singh, Itaru Endo, Robert M. Hoffman	32
9	Significance of HMGA2 expression as independent poor prognostic marker in perihilar and distal cholangiocarcinoma resected with curative intent 2020 ·European Journal of Surgical Oncology ·T Takahashi, Hideya Kawaji, (unknown), Yoshihide Hayashizaki, Takashi Murakami, Yasuhiro Yabushita, Yuki Homma, Takafumi Kumamoto, Ryusei Matsuyama, Itaru Endo	2
10	A case of triple digestive tract reconstruction in chronic pancreatitis complicated with bile ductal stenosis, duodenal stenosis, and portal vein stenosis: a case report 2020 ·SHILAP Revista de lepidopterología ·Yuka Abe, Takafumi Kumamoto, (unknown), Kentaro Miyake, Yasuhiro Yabushita, Yu Sawada, Yuki Homma, Kazuhisa Takeda, Ryusei Matsuyama, Itaru Endo	0
11	MiR-194-5p in Pancreatic Ductal Adenocarcinoma Peritoneal Washings is Associated with Peritoneal Recurrence and Overall Survival in Peritoneal Cytology-Negative Patients 2019 ·Annals of Surgical Oncology ·(unknown), Yukihiko Hiroshima, Rintaro Mori, Yusuke Saigusa, Takashi Murakami, Yasuhiro Yabushita, Yu Sawada, Yuki Homma, Takafumi Kumamoto, Ryusei Matsuyama, Itaru Endo	10
12	Efficacy of prolonged elemental diet therapy after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A pilot prospective randomized trial (UMIN000004108) 2019 ·Clinical Nutrition ESPEN ·Rintaro Mori, Ryusei Matsuyama, Koichi Taniguchi, (unknown), Kentaro Miyake, (unknown), Yuki Homma, (unknown), Takafumi Kumamoto, Daisuke Morioka, Itaru Endo	7
13	High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater 2019 ·World Journal of Surgical Oncology ·Takashi Murakami, Ryusei Matsuyama, Michio Ueda, (unknown), Yuki Homma, (unknown), (unknown), (unknown), Tadao Fukushima, (unknown), Kenichi Yoshida, (unknown), Robert M. Hoffman, Itaru Endo	6
14	The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model 2019 ·Biomedicine & Pharmacotherapy ·Kentaro Miyake, Takashi Higuchi, Hiromichi Oshiro, Zhiying Zhang, Norihiko Sugisawa, Jun Ho Park, Sahar Razmjooei, Yuki Katsuya, (unknown), Yunfeng Li, Scott D. Nelson, Takashi Murakami, Yuki Homma, Yukihiko Hiroshima, Ryusei Matsuyama, Michael Bouvet, Sant P. Chawla, Shree Ram Singh, Itaru Endo, Robert M. Hoffman	8
15	Pure laparoscopic right posterior sectionectomy using the caudate lobe-first approach 2019 ·Surgical Endoscopy ·Yuki Homma, Goro Honda, Masanao Kurata, Yusuke Ome, (unknown), Jun Yamamoto	20
16	Intrahepatic Glissonean Pedicle Approach to Segment 7 from the Dorsal Side During Laparoscopic Anatomic Hepatectomy of the Cranial Part of the Right Liver 2017 ·Journal of the American College of Surgeons ·Yukihiro Okuda, Goro Honda, Shin Kobayashi, Katsunori Sakamoto, Yuki Homma, (unknown), (unknown)	30
17	Significance of Vascular Resection and Reconstruction in Surgery for Hilar Cholangiocarcinoma: With Special Reference to Hepatic Arterial Resection and Reconstruction 2016 ·Annals of Surgical Oncology ·Ryusei Matsuyama, Rintaro Mori, (unknown), Yuki Homma, Takafumi Kumamoto, Kazuhisa Takeda, Daisuke Morioka, Jiro Maegawa, Itaru Endo	40
18	Low Infiltration of Peritumoral Regulatory T Cells Predicts Worse Outcome Following Resection of Colorectal Liver Metastases 2014 ·Annals of Surgical Oncology ·Kazuya Nakagawa, Kuniya Tanaka, Yuki Homma, Kazunori Nojiri, Takafumi Kumamoto, Kazuhisa Takeda, Itaru Endo	34
19	Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma 2013 ·Annals of Surgical Oncology ·Yuki Homma, Koichi Taniguchi, Takashi Murakami, Kazuya Nakagawa, Masatoshi Nakazawa, Ryusei Matsuyama, Rintaro Mori, Kazuhisa Takeda, Michio Ueda, Yasushi Ichikawa, Kuniya Tanaka, Itaru Endo	57
20	Changes in the immune cell population and cell proliferation in peripheral blood after gemcitabine-based chemotherapy for pancreatic cancer 2013 ·Clinical & Translational Oncology ·Yuki Homma, K Taniguchi, Mitsuru Nakazawa, Ryusei Matsuyama, Rintaro Mori, K. Takeda, Yasushi Ichikawa, Kuniya Tanaka, Itaru Endo	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact